clinical study retractions – Page 7

Psych journal in revolt as it publishes paper saying masturbation and gay sex are harmful

Several psychiatry researchers have been unsuccessfully seeking distance from a dodgy journal with which they’re affiliated – and which has now published an article claiming homosexuality and masturbation deserve to be considered (or reconsidered, as the case may be) mental illnesses.

The 2021 paper, “Review of Removing Homosexuality and Masturbation from the List of Sexual Dysfunctions in DSM,” was written by Sayed Ali Marashi, of the Department of Psychology at Shahid Chamran University of Ahvaz, in Iran It appeared in Clinical Schizophrenia & Related Psychoses.

Oddly, the header text on the paper reads “Metallurgical Investigation of Tie Rod used for lifting Ferro-Alloy during Steel Making: A Safety Issues.”

According to the article:

Journal retracts a paper it published with a missing table after author fails to provide it

Mark Oniffrey, CC BY-SA 4.0, via Wikimedia Commons

Can you retract something that never existed in the first place? At least one journal thinks the answer to that conundrum is yes.

That journal would be Medicine. In September 2020, the Wolters Kluwer journal published a paper titled “Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol” by a group in China led by Linyu Yang, of the Department of Orthopedics at the Affiliated Hospital of Southwest Medical University, in Sichuan.

The article promised – but failed to deliver – a “Table 1”, an omission the peer reviewers and journal staff missed during the production process. Five months later, said table still had not materialized, prompting the following notice:

More than 100 of an anesthesiologist’s papers retracted

There’s a new entry on the Retraction Watch Leaderboard. And this one is also the fourth member of the Retraction Watch Century Club.

An anesthesiology researcher in Japan is now up to 117 retractions – putting him third on our list of most-retracted authors.

Hironobu Ueshima, formerly of Showa University Hospital in Tokyo, was found to have committed misconduct in 142 papers, according to a pair of investigations, one by his erstwhile institution and another by the Japanese Society of Anesthesiologists (JSA). We first reported on the existence of the investigation in June 2020, some three months after Australian anesthesiologist and journal editor John Loadsman raised concerns with journals involved in the case.

Philadelphia-area lung researcher up to six retractions

A lung researcher is up to six retractions for problematic images.

Dilip Shah’s last academic post was at Cooper University Hospital in Camden, N.J., where he worked as a post-doc in the lab of Vineet Bhandari. While there, Shah landed first authorship on a 2020 article in the European Respiratory Journal titled “miR-184 mediates hyperoxia-induced injury by targeting cell death and angiogenesis signalling pathways in the developing lung.”

According to the notice:

Two abstracts about unapproved heart technology retracted

A group of heart researchers have lost two meeting abstracts after, according to one of the authors, companies said the data were proprietary and couldn’t be published. But it’s not clear the companies did so.

The studies appeared in the journal Heart Rhythm, the official journal of the Heart Rhythm Society, and were presented at the group’s 2021 annual meeting.

The first author on both abstracts was Andrea Natale, a cardiac electrophysiologist at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin. We wrote about Natale in 2016, after the researcher lost a paper in the Journal of the American College of Cardiology – again based on work he presented at the Heart Rhythm Society conference about which he raised concerns over industry meddling. (Natale disputes that he was the first author on the now-retracted posters, for reasons that aren’t clear to us.)

Researchers ‘devastated’ after finding manipulated data in study of pediatric brain tumors

An international group of cancer researchers has lost an influential 2020 paper in Nature Neuroscience after finding problems with the data that triggered an institutional investigation.

The article, “Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma,” represented a potentially major advance in the treatment of pediatric brain tumors, according to Robert Wechsler-Reya, the director of the Tumor Initiation & Maintenance Program at the Sanford Burnham Prebys Medical Discovery Institute, in La Jolla, Calif., and the senior author of the paper, which has been cited 17 times, per Clarivate Analytics’ Web of Science:

Exercise researcher earns more retractions as investigations mount

Co-author James Steele, one of the sleuths who brought the issues to attention

Retractions are slowly stacking up for an exercise researcher in Brazil whose work has come under scrutiny by data sleuths, including a couple of his erstwhile co-authors. The concerns prompted an investigation by his former institution into one of his academic supervisors, who may be facing sanctions, Retraction Watch has learned.

In June 2020, the sleuths posted a preprint calling for the retraction of seven papers by the researcher, Matheus Barbalho, a PhD student at the Centro de Ciências Biológicas e da Saúde, part of the Universidade da Amazônia, in Belém. The reason, according to the sleuths – who included James Steele and James Fisher, of Solent University in the United Kingdom, both of whom were co-authors on papers with Barbalho: the data were, in their view “atypical, improbable, and to put it bluntly, pretty weird.”

Since then, journals have retracted two of Barbalho’s papers (he had lost one in April 2020), citing concerns about the data in the articles.

AHA “regrets any confusion” and is reviewing meeting policies after outcry over Covid-19 vaccine abstract

Days after a leading heart journal issued an expression of concern for a meeting abstract suggesting that vaccines against Covid-19 may cause cardiac damage, its publisher, the American Heart Association (AHA), says it is reviewing how it screens such submissions.

As we reported late last month, “Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning,” was presented at the AHA’s 2021 Scientific Sessions in mid-November and was published in Circulation.

The author was Steven Gundry, a cardiac surgeon by training who now sells dietary supplements on his website. Gundry also sees patients at the Center for Restorative Medicine and International Heart & Lung Institute in California and offers advice on YouTube. (His critics say what Gundry peddles costs much more than it’s worth.)

After an outcry, Circulation flagged the published poster with the following notice:

Authors retract, resubmit “very poorly conducted” meta-analysis of COVID-19 treatment

A journal has retracted a meta-analysis on Covid-19 after concerned readers complained about the quality — or lack thereof — of the study.

The article, “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients,” appeared in Therapeutic Advances in Chronic Disease, a SAGE title.

According to the retraction notice:

Group’s second paper on potential treatments for COVID-19 is retracted

A group of researchers in Egypt have lost a second paper on possible treatments for Covid-19 after questions were raised about the legitimacy of their trial findings — and additional retractions might be coming soon.

As we reported in September, the group lost an article in Scientific Reports about a purported trial comparing favipiravir and hydroxychloroquine to treat the infection.

That move followed an expression of concern, issued in early August, for a paper in the Archives of Virology by Dabbous and his colleagues about favipiravir, titled “Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.”

The journal has now retracted the article:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: